Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Principais autores: | Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V |
---|---|
Formato: | Conference item |
Idioma: | English |
Publicado em: |
Wiley
2019
|
Registros relacionados
-
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
por: Chen, W, et al.
Publicado em: (2018) -
Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
por: Xue, L, et al.
Publicado em: (2018) -
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
por: Hardman, C, et al.
Publicado em: (2019) -
Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
por: Xue, L, et al.
Publicado em: (2019) -
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
por: Hardman, CS, et al.
Publicado em: (2021)